Clinical Trial Update: Evaluation of Efficacy and Tolerability of Hizentra® [NA]

View source ↗

Summary

This entry provides an update on a clinical trial evaluating the efficacy and tolerability of Hizentra for primary immunodeficiency disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency Disorders

Drugs mentioned

• Hizentra (subcutaneous immunoglobulin (IgG))

Snippet

Sponsor: University of South Florida | Conditions: Primary Immunodeficiency Disorders | NA | Status: UNKNOWN